Janet Freeman-Daily on Why Patients Should Attend the ASCO Meeting

July 27, 2015
Janet Freeman-Daily
Janet Freeman-Daily

Janet Freeman-Daily is a writer, speaker, science geek and epatient with metastatic lung cancer. She uses her systems engineering background to translate the experience and science of lung cancer treatment and research into language other patients can understand. She comoderates the Lung Cancer Social Media (#LSCM) Chat on Twitter and blogs at www.grayconnections.wordpress.com.

Janet Freeman-Daily on why patients should attend the annual meeting of the American Society of Clinical Oncology (ASCO).

We spoke with Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago. Here, Freeman-Daily discusses why patients should attend the meeting.

Related Content:

CURE TV
Understanding That Not All Lung Cancer Cases Are Linked to Smoking
Breaking Down Advancements in Prostate Cancer Care
Experts Highlight Notable Advances in Colorectal Cancer at 2025 ESMO